Oakwood Vision Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2914 Oakwood Blvd, Hollywood, FL 33020 Phone: 954-921-5330 |
Tonika Lovone Optometrist Medicare: Not Enrolled in Medicare Practice Location: 301 S State Road 7, Hollywood, FL 33023 Phone: 754-260-6709 |
James M Beranek Od Pa Optometrist Medicare: Medicare Enrolled Practice Location: 3277 Hollywood Blvd, Hollywood, FL 33021 Phone: 954-987-6500 Fax: 954-966-2020 |
Dr. James Matthew Beranek, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3277 Hollywood Blvd, Hollywood, FL 33021 Phone: 954-987-6500 Fax: 954-966-2020 |
Druey Vision Group, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 333 S State Road 7 Unit A, Hollywood, FL 33023 Phone: 561-275-2020 |
Eyes On The Job Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4330 Sheridan St Ste 102, Hollywood, FL 33021 Phone: 954-998-4344 |
Dr. Marcus Leonardo Singh, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 520 N 71st Ave, Hollywood, FL 33024 Phone: 754-204-8078 |
Dr. Bluma Dukesz, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2914 Oakwood Blvd, Hollywood, FL 33020 Phone: 954-921-5330 |
Jerry Siegel Od Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5924 Sheridan St, Hollywood, FL 33021 Phone: 561-703-3230 |
Dr. Justine Chen, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 3339 Sheridan St, Hollywood, FL 33021 Phone: 954-962-6627 Fax: 954-962-0910 |
Dr. Jackie L. Schwartz, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2605 N Hiatus Rd, Hollywood, FL 33026 Phone: 954-433-4770 Fax: 954-443-4266 |
Lisbet Vidal, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4011 Grant St, Hollywood, FL 33021 Phone: 786-543-5340 |
Broward Optimum Eye Care P.a. Optometrist Medicare: Medicare Enrolled Practice Location: 3900 Fern Forest Rd, Hollywood, FL 33026 Phone: 954-304-2724 |
Dr. Barry M Kay, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2011 Harrison St, Hollywood, FL 33020 Phone: 954-923-5367 Fax: 954-923-3484 |
Dr. Bruce Fleischer, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2914 Oakwood Blvd, Hollywood, FL 33020 Phone: 954-921-5330 Fax: 305-821-7605 |
Heiden & Heiden Pa Optometrist Medicare: Medicare Enrolled Practice Location: 2019a Hollywood Blvd, Hollywood, FL 33020 Phone: 954-922-5210 Fax: 954-925-2190 |
Dr. Felix David Torres, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 5509 Hayes St, Hollywood, FL 33021 Phone: 305-409-3991 |
Bluma Dukesz Od Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3240 N 37th St, Hollywood, FL 33021 Phone: 917-455-2597 |
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2011 Harrison St, Hollywood, FL 33020 Phone: 954-923-5367 Fax: 954-923-3484 |
Megan Nicole Demartino, OD Optometrist Medicare: Medicare Enrolled Practice Location: 1050 N Federal Hwy, Hollywood, FL 33020 Phone: 954-458-2112 |
News Archive
Triple-S Management Corporation, the largest managed care company in Puerto Rico, today announced consolidated revenues of $507.3 million and operating income of $15.4 million for the three months ended September 30, 2009. Net income of $18.1 million, or $0.62 per diluted share, includes an after tax net gain of $6.3 million, or $0.22 per share, in net realized and unrealized gains on investments and derivatives.
As children with single-ventricle disease, a complex and severe heart defect, undergo a series of three reconstructive surgeries, pediatric researchers have detected higher rates of brain abnormalities at each stage.
Spinal Modulation, Inc. announced today the completion of its $27.4 million Series C financing. Johnson & Johnson Development Corporation (JJDC) joined existing major investors including DeNovo Ventures, ePlanet/DFJ, Kleiner Perkins Caufield & Byers, and MedVenture Associates in this financing. DFJ/InCube Ventures and Raffles Venture Partners are additional new investors.
Individuals with Parkinson's disease were more likely to have a neurochemical response to a placebo medication if they were told they had higher odds of receiving an active drug, according to a report in the August issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Protalix BioTherapeutics, Inc., announced today that the Company's New Drug Application (NDA) for taliglucerase alfa has been accepted for review by the U.S. Food and Drug Administration (FDA). The FDA granted taliglucerase alfa a standard review time of ten months, assigning a Prescription Drug User Fee Act (PDUFA) action date of February 25, 2011.
› Verified 6 days ago